January 11, 2025 - 03:31

All three major US stock indices experienced significant declines today, with each dropping over 1.5%. The Nasdaq Composite and Dow Jones Industrial Average both fell by 1.63%, reacting to the latest jobs data released by the US Bureau of Labor Statistics. In December, the economy added 256,000 nonfarm payroll jobs, a figure that exceeded analysts' expectations.
This robust job growth has raised concerns among investors about the potential implications for the Federal Reserve's interest rate policies moving forward. The market's reaction suggests that traders are wary of tighter monetary policy in response to the strong labor market. As bond yields fluctuate in response to these developments, market analysts are closely monitoring how these economic indicators will influence future decisions by the Federal Reserve.
The day’s market performance underscores the ongoing volatility as investors navigate the complex interplay between economic data and central bank policy.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...